REQUEST A DEMO
Total
USD $0.00
Search more companies

Rozsa Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Rozsa Pharma Kft. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Rozsa Pharma Kft. is a company based in Hungary, with its head office in Budapest. The enterprise operates in the Pharmacies and Drug Stores industry. The company was established on April 29, 2008. Rozsa Pharma Kft. currently employs 11 (2023) people. From the latest financial highlights, Rozsa Pharma Kft. reported a net sales revenue increase of 16.28% in 2022. A growth of 5.95% was recorded in its total assets. In 2022, Rozsa Pharma Kft.’s net profit margin decreased by 1.58%.

Headquarters
Rozsa utca 16-18.
Budapest; Budapest; Postal Code: 1042

Contact Details: Purchase the Rozsa Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Rozsa Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Rozsa Pharma Kft. report to view the information.
Registered Capital:
Purchase the Rozsa Pharma Kft. report to view the information.
Financial Auditors:
Purchase the Rozsa Pharma Kft. report to view the information.
Incorporation Date:
April 29, 2008
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Rozsa Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
16.28%
Total operating revenue
16.33%
Operating profit (EBIT)
-23.6%
EBITDA
-13.58%
Net Profit (Loss) for the Period
-32.48%
Total assets
5.95%
Total equity
17.88%
Operating Profit Margin (ROS)
-1.44%
Net Profit Margin
-1.58%
Return on Equity (ROE)
-17.05%
Quick Ratio
-0.2%
Cash Ratio
-0.37%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?